Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.083 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |